214 related articles for article (PubMed ID: 34634164)
21. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
[TBL] [Abstract][Full Text] [Related]
22. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS).
Verleden SE; Vandermeulen E; Ruttens D; Vos R; Vaneylen A; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM; Verleden GM
Semin Respir Crit Care Med; 2013 Jun; 34(3):352-60. PubMed ID: 23821509
[TBL] [Abstract][Full Text] [Related]
23. Primary graft dysfunction grade 3 following pediatric lung transplantation is associated with chronic lung allograft dysfunction.
Wong W; Johnson B; Cheng PC; Josephson MB; Maeda K; Berg RA; Kawut SM; Harhay MO; Goldfarb SB; Yehya N; Himebauch AS
J Heart Lung Transplant; 2023 May; 42(5):669-678. PubMed ID: 36639317
[TBL] [Abstract][Full Text] [Related]
24. Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.
Levy L; Huszti E; Renaud-Picard B; Berra G; Kawashima M; Takahagi A; Fuchs E; Ghany R; Moshkelgosha S; Keshavjee S; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2020 Aug; 39(8):761-770. PubMed ID: 32418864
[TBL] [Abstract][Full Text] [Related]
25. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
Benden C; Haughton M; Leonard S; Huber LC
J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
[TBL] [Abstract][Full Text] [Related]
26. Role of 18F-FDG PET/CT in Restrictive Allograft Syndrome After Lung Transplantation.
Verleden SE; Gheysens O; Goffin KE; Vanaudenaerde BM; Verbeken EK; Weynand B; Van Raemdonck DE; Verleden GM; Vos R
Transplantation; 2019 Apr; 103(4):823-831. PubMed ID: 30086092
[TBL] [Abstract][Full Text] [Related]
27. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
[TBL] [Abstract][Full Text] [Related]
28. Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial.
Gottlieb J; Verleden GM; Perchl M; Valtin C; Vallee A; Brugière O; Bravo C
PLoS One; 2021; 16(12):e0260881. PubMed ID: 34941934
[TBL] [Abstract][Full Text] [Related]
29. Lung Density Analysis Using Quantitative Chest CT for Early Prediction of Chronic Lung Allograft Dysfunction.
Horie M; Levy L; Houbois C; Salazar P; Saito T; Pakkal M; OʼBrien C; Sajja S; Brock K; Yasufuku K; Keshavjee S; Paul N; Martinu T
Transplantation; 2019 Dec; 103(12):2645-2653. PubMed ID: 31343572
[TBL] [Abstract][Full Text] [Related]
30. Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?
Verleden GM; Godinas L; Vos R; Verleden SE
Curr Opin Organ Transplant; 2022 Jun; 27(3):211-216. PubMed ID: 35649111
[TBL] [Abstract][Full Text] [Related]
31. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
[No Abstract] [Full Text] [Related]
32. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
[TBL] [Abstract][Full Text] [Related]
33. Detection of chronic lung allograft dysfunction using ventilation-weighted Fourier decomposition MRI.
Voskrebenzev A; Greer M; Gutberlet M; Schönfeld C; Renne J; Hinrichs J; Kaireit T; Welte T; Wacker F; Gottlieb J; Vogel-Claussen J
Am J Transplant; 2018 Aug; 18(8):2050-2060. PubMed ID: 29607606
[TBL] [Abstract][Full Text] [Related]
34. High-Resolution CT Findings of Obstructive and Restrictive Phenotypes of Chronic Lung Allograft Dysfunction: More Than Just Bronchiolitis Obliterans Syndrome.
Hota P; Dass C; Kumaran M; Simpson S
AJR Am J Roentgenol; 2018 Jul; 211(1):W13-W21. PubMed ID: 29792746
[TBL] [Abstract][Full Text] [Related]
35. Lung volumes predict survival in patients with chronic lung allograft dysfunction.
Kneidinger N; Milger K; Janitza S; Ceelen F; Leuschner G; Dinkel J; Königshoff M; Weig T; Schramm R; Winter H; Behr J; Neurohr C
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404648
[TBL] [Abstract][Full Text] [Related]
36. Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience.
Sugimoto S; Yamamoto H; Kurosaki T; Otani S; Okazaki M; Yamane M; Toyooka S; Oto T
Surg Today; 2019 Aug; 49(8):686-693. PubMed ID: 30790054
[TBL] [Abstract][Full Text] [Related]
37. Montelukast in chronic lung allograft dysfunction after lung transplantation.
Vos R; Eynde RV; Ruttens D; Verleden SE; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck DE; Verleden GM;
J Heart Lung Transplant; 2019 May; 38(5):516-527. PubMed ID: 30638839
[TBL] [Abstract][Full Text] [Related]
38. Early extracorporeal photopheresis treatment is associated with better survival in patients with chronic or recurrent acute lung allograft dysfunction.
Gautschi F; Vogelmann T; Ortmanns G; Knörr F; Steinack C; Hage R; Nägeli M; Schuurmans MM
J Clin Apher; 2024 Jun; 39(3):e22128. PubMed ID: 38829041
[TBL] [Abstract][Full Text] [Related]
39. Phenotyping CLAD after single lung transplant: Limits and prognostic assessment of the 2019 ISHLT classification system.
Berra G; Huszti E; Levy L; Kawashima M; Fuchs E; Renaud-Picard B; Riddell P; Dias O; Rajagopala S; Ulahannan A; Ghany R; Singer LG; Tikkanen J; Martinu T
J Heart Lung Transplant; 2022 May; 41(5):599-607. PubMed ID: 35351385
[TBL] [Abstract][Full Text] [Related]
40. Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.
Saito T; Takahashi H; Kaneda H; Binnie M; Azad S; Sato M; Waddell TK; Cypel M; Liu M; Keshavjee S
Am J Transplant; 2013 Dec; 13(12):3192-201. PubMed ID: 24164971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
